Skip to Content

M LN3 (Lamivudine 300 mg)

Pill with imprint M LN3 is White, Elliptical / Oval and has been identified as Lamivudine 300 mg. It is supplied by Mylan Pharmaceuticals Inc..

Lamivudine is used in the treatment of hepatitis b; occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M LN3

Lamivudine

Imprint:
M LN3
Strength:
300 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-5170

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide